Balyasny Asset Management
CINC

Balyasny Asset Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Balyasny Asset Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,461
Closed -$325K – 2856
2022
Q4 		$325K Buy
+26,461
New +$325K ﹤0.01% 1539